Regulatory action follows findings related to unauthorised labelling, recall compliance, drug storage and discrepancies in stock records
The new facility will more than triple Evonik’s existing manufacturing capacity for advanced pharmaceutical products in Vancouver
Lilly said Mounjaro is the first and only GIP and GLP-1 receptor agonist shown to reduce the risk of major adverse cardiovascular events in this population
The proposed venture will create a locally based manufacturing facility for the manufacture, processing, testing, packaging, marketing and supply of male condoms and related products
.png)
The system also features the Aegis Detector System, engineered to enhance image clarity and low-contrast detectability while supporting low-dose imaging protocols
Women’s longevity is the top wellness trend of the year
The programme will focus on research-to-policy translation, implementation science, real-world evidence, community participation, research integrity and AI in health research
£375,000 Innovate UK-backed partnership to use data analytics and predictive modelling to improve formulation, product development and decision-making
Board approves Mexico and Canada subsidiaries as the company advances international expansion and integrates its Rs. 91 crore Apnar Pharma acquisition
The company currently holds 96% of Bharat Serums and Vaccines directly, while the remaining 4% is held through its wholly owned subsidiary, Appian Properties
Field data indicates that joint and body pain and other musculoskeletal conditions account for 22% of commonly observed conditions, followed by respiratory tract infections at 18% and common cold and flu at 15%
The company plans to use proceeds from the fresh issue primarily for repayment or pre-payment of borrowings, capital expenditure at its Hyderabad facilities
The company’s Sustainability Report 2025–26 highlights progress across ESG priorities
The results support advancing both programs as it seeks to develop therapies for major unmet needs in eye care.
Robenacoxib Injection is indicated for postoperative pain and inflammation associated with soft tissue surgery in dogs
The technology combines a novel fluorescent probe, TZ-48, with a smartphone-integrated system called ADxFluor
The company said it intends to challenge the order through the appropriate appellate process
According to company’s regulatory filing, the inspection was conducted from August 17 to August 25, 2026, and concluded with the issuance of a Form 483 containing seven observations
The initial portfolio comprises products across sterile injectables, biologics and topical formulations to be manufactured at Aurigene’s facilities in India
Subscribe To Our Newsletter & Stay Updated
